UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Postnatal management of fetal hydronephrosis

Author
Laurence S Baskin, MD, FAAP
Section Editor
Duncan Wilcox, MD
Deputy Editor
Melanie S Kim, MD

INTRODUCTION

Fetal hydronephrosis (dilation of the renal pelvis) is a common, readily diagnosed finding on antenatal ultrasound examination, which may be a transient benign condition or be associated with significant congenital anomalies of the kidney and urinary tract (CAKUT). The goals of postnatal management of infants with fetal hydronephrosis is to identify those with clinically significant CAKUT while avoiding unnecessary testing in patients with physiologic or clinically insignificant hydronephrosis. In addition, early identification of infants with significant disease allows initiation of interventional therapy that may minimize adverse effects of CAKUT.

Postnatal management of infants diagnosed with fetal hydronephrosis is reviewed here. The definition, etiology, and prenatal issues of fetal hydronephrosis and specific urologic conditions that may present as fetal hydronephrosis are discussed separately. (See "Overview of fetal hydronephrosis" and "Congenital ureteropelvic junction obstruction" and "Primary megaureter in infants and children" and "Ectopic ureter".)

BACKGROUND AND MANAGEMENT GOALS

In most cases, renal pelvic dilation diagnosed in utero is a transient, physiologic state, however, congenital anomalies of the kidney and urinary tract (CAKUT) can present with fetal hydronephrosis due to urinary tract obstruction and vesicoureteral reflux (VUR). These conditions may be associated with impaired normal renal development and/or cause renal injury. Nevertheless, the majority of cases of fetal hydronephrosis are not clinically significant, and therefore excessive concern may lead to unnecessary testing of the newborn infant and anxiety for parents and health care providers.

The goals of postnatal management of infants with fetal hydronephrosis are to identify patients with significant CAKUT while avoiding unnecessary testing in patients with physiologic or clinically insignificant hydronephrosis. Evaluation includes physical examination and the use of imaging studies to detect abnormalities that will require postnatal intervention.

There is not a single test or finding that accurately differentiates infants with significant disease from those who are normal or have insignificant findings. In our practice, we use an approach based upon the presence of predicative factors (bilateral involvement and severity of persistent fetal hydronephrosis) for postnatal management that limits unnecessary testing and minimizes parental distress [1,2]. (See 'Approach' below and "Overview of fetal hydronephrosis", section on 'Congenital anomalies of the kidney and urinary tract (CAKUT)'.)

               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Aug 29 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Josephson S. Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management. BJU Int 2000; 85:973.
  2. Ransley PG, Dhillon HK, Gordon I, et al. The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol 1990; 144:584.
  3. Dias CS, Silva JM, Pereira AK, et al. Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction. J Urol 2013; 190:661.
  4. Coplen DE, Austin PF, Yan Y, et al. The magnitude of fetal renal pelvic dilatation can identify obstructive postnatal hydronephrosis, and direct postnatal evaluation and management. J Urol 2006; 176:724.
  5. Woodward M, Frank D. Postnatal management of antenatal hydronephrosis. BJU Int 2002; 89:149.
  6. Chung S, Majd M, Rushton HG, Belman AB. Diuretic renography in the evaluation of neonatal hydronephrosis: is it reliable? J Urol 1993; 150:765.
  7. Taylor A Jr, Clark S, Ball T. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates. Clin Nucl Med 1994; 19:575.
  8. Gordon I. Diuretic renography in infants with prenatal unilateral hydronephrosis: an explanation for the controversy about poor drainage. BJU Int 2001; 87:551.
  9. Koff SA. Postnatal management of antenatal hydronephrosis using an observational approach. Urology 2000; 55:609.
  10. Gordon I, Dhillon HK, Gatanash H, Peters AM. Antenatal diagnosis of pelvic hydronephrosis: assessment of renal function and drainage as a guide to management. J Nucl Med 1991; 32:1649.
  11. de Bruyn R, Marks SD. Postnatal investigation of fetal renal disease. Semin Fetal Neonatal Med 2008; 13:133.
  12. Grattan-Smith JD, Little SB, Jones RA. MR urography evaluation of obstructive uropathy. Pediatr Padiol 2008; 38 Suppl 1:S49.
  13. Josephson S, Dhillon HK, Ransley PG. Post-natal management of antenatally detected, bilateral hydronephrosis. Urol Int 1993; 51:79.
  14. Dacher JN, Mandell J, Lebowitz RL. Urinary tract infection in infants in spite of prenatal diagnosis of hydronephrosis. Pediatr Radiol 1992; 22:401.
  15. Walsh TJ, Hsieh S, Grady R, Mueller BA. Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology 2007; 69:970.
  16. Coelho GM, Bouzada MC, Lemos GS, et al. Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation. J Urol 2008; 179:284.
  17. Szymanski KM, Al-Said AN, Pippi Salle JL, Capolicchio JP. Do infants with mild prenatal hydronephrosis benefit from screening for vesicoureteral reflux? J Urol 2012; 188:576.
  18. Braga LH, Mijovic H, Farrokhyar F, et al. Antibiotic prophylaxis for urinary tract infections in antenatal hydronephrosis. Pediatrics 2013; 131:e251.
  19. Lidefelt KJ, Herthelius M, Soeria-Atmadja S. Antenatal renal pelvis dilatation: 2-year follow-up with DMSA scintigraphy. Pediatr Nephrol 2009; 24:533.
  20. Lidefelt KJ, Herthelius M. Antenatal hydronephrosis: infants with minor postnatal dilatation do not need prophylaxis. Pediatr Nephrol 2008; 23:2021.
  21. Lidefelt KJ, Ek S, Mihocsa L. Is screening for vesicoureteral reflux mandatory in infants with antenatal renal pelvis dilatation? Acta Paediatr 2006; 95:1653.
  22. Song SH, Lee SB, Park YS, Kim KS. Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis? J Urol 2007; 177:1098.
  23. Lee JH, Choi HS, Kim JK, et al. Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008; 179:1524.
  24. Mamì C, Paolata A, Palmara A, et al. Outcome and management of isolated moderate renal pelvis dilatation detected at postnatal screening. Pediatr Nephrol 2009; 24:2005.
  25. Alconcher LF, Tombesi MM. Natural history of bilateral mild isolated antenatal hydronephrosis conservatively managed. Pediatr Nephrol 2012; 27:1119.
  26. Sidhu G, Beyene J, Rosenblum ND. Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis. Pediatr Nephrol 2006; 21:218.
  27. Matsui F, Shimada K, Matsumoto F, Takano S. Late recurrence of symptomatic hydronephrosis in patients with prenatally detected hydronephrosis and spontaneous improvement. J Urol 2008; 180:322.